+Compare
HEXO
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
107.35M

HEXO Price Prediction, HEXO Corp AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
HEXO Trading results, last 6 months
AI Robots NameP/L
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EST Dec 05, 2022

HEXO in -4.44% downward trend, falling for three consecutive days on November 22, 2022

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HEXO declined for three days, in 328 of 361 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Aroon Indicator for HEXO entered a downward trend on December 05, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 02, 2022. You may want to consider a long position or call options on HEXO as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HEXO just turned positive on December 02, 2022. Looking at past instances where HEXO's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

HEXO moved above its 50-day moving average on December 02, 2022 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HEXO advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

HEXO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.480) is normal, around the industry mean (5.923). P/E Ratio (0.000) is within average values for comparable stocks, (48.008). HEXO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.500). HEXO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.024). P/S Ratio (0.510) is also within normal values, averaging (115.015).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HEXO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HEXO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

HEXO is expected to report earnings to fall 89.09% to -1 cents per share on December 19

HEXO Corp HEXO Stock Earnings Reports
Q4'22
Est.
$-0.01
Q3'22
Missed
by $0.08
Q2'22
Est.
$-0.26
Q1'22
Missed
by $1.49
Q4'21
Missed
by $0.03
The last earnings report on November 01 showed earnings per share of -13 cents, missing the estimate of -5 cents. With 3.78M shares outstanding, the current market capitalization sits at 107.35M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.11B. The market cap for tickers in the group ranges from 246 to 81.18B. MKKGY holds the highest valuation in this group at 81.18B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was -19%. SHPH experienced the highest price growth at 95%, while NRXCF experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was 25% and the average quarterly volume growth was -54%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 72
Price Growth Rating: 66
SMR Rating: 57
Profit Risk Rating: 92
Seasonality Score: 24 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I. Advisor
published General Information

General Information

pharmaceutical, medical cannabis, marijuana

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
120 de la Rive Road
Phone
+1 844 406-1852
Employees
1270
Web
https://www.hexocorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DEFTF0.13N/A
N/A
VALOUR
GLATF2.71N/A
N/A
Global Atomic Corp
NSRGF120.45N/A
N/A
Nestle Sa
PRYMY17.67N/A
N/A
Prysmian SPA Milano
SSEZY21.09N/A
N/A
SSE Plc

HEXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HEXO has been closely correlated with OGI. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if HEXO jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HEXO
1D Price
Change %
HEXO100%
-3.65%
OGI - HEXO
72%
Closely correlated
-3.36%
TLRY - HEXO
70%
Closely correlated
+2.18%
CRON - HEXO
69%
Closely correlated
+1.16%
SNDL - HEXO
67%
Closely correlated
-0.32%
CGC - HEXO
67%
Closely correlated
+0.70%
More